Sponsor

University of California, Irvine

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of California, Irvine appears in 124 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials124
Recruiting shown13
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)NCT07711691 · lead sponsor · 2026-09-16
RECRUITING
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in IndiaNCT07209917 · lead sponsor · 2026-02-01
RECRUITING
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialNCT07447050 · lead sponsor · 2025-12-23
RECRUITING
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung CancerNCT07062172 · lead sponsor · 2025-05-08
RECRUITING
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesNCT07064018 · lead sponsor · 2025-04-30
RECRUITING
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)NCT06783751 · lead sponsor · 2025-03-21
RECRUITING
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialNCT06580002 · lead sponsor · 2024-12-02
RECRUITING
Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse EffectsNCT06221800 · lead sponsor · 2024-01-31
RECRUITING
Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric SurgeryNCT05975580 · lead sponsor · 2023-08-29
RECRUITING
Acupuncture Therapy and HypertensionNCT05530512 · lead sponsor · 2023-01-01
RECRUITING
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast CancerNCT05524584 · lead sponsor · 2022-08-31
RECRUITING
Biomarker Exploration in Aging, Cognition and NeurodegenerationNCT03860857 · lead sponsor · 2018-05-01
RECRUITING
Effect of Electro-Acupuncture on Blood PressureNCT00932139 · lead sponsor · 2003-02-01
RECRUITING
HOPE Intervention for FitnessNCT07114822 · lead sponsor · 2026-10-01
NOT_YET_RECRUITING
Optimizing Preeclampsia Postpartum With Point-of-care UltrasoundNCT07167862 · lead sponsor · 2026-06-15
NOT_YET_RECRUITING
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer EvaluationNCT07568756 · lead sponsor · 2026-05-01
NOT_YET_RECRUITING
Therapy and Tech StudyNCT07225192 · lead sponsor · 2025-11-01
NOT_YET_RECRUITING
Conscious Pregnancy: Supporting Maternal Cardiometabolic Health With MindfulnessNCT06898658 · lead sponsor · 2025-03-27
COMPLETED
Youth Nominated Support TeamNCT05558332 · lead sponsor · 2025-03-12
ACTIVE_NOT_RECRUITING
Feasibility and Preliminary Effects of Fasting-Mimicking Diet in Asian Americans With PrediabetesNCT06518798 · lead sponsor · 2024-08-12
COMPLETED
Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)NCT06225414 · lead sponsor · 2024-02-12
COMPLETED
Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia TrialNCT05509881 · lead sponsor · 2023-12-12
UNKNOWN
Empowering Patients' Lung Cancer Screening UptakeNCT06000683 · lead sponsor · 2023-10-13
COMPLETED
Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney DiseaseNCT05514184 · lead sponsor · 2023-10-01
UNKNOWN
Analysis of Lung Cancer Tissue With Spatial Frequency Domain ImagingNCT06549088 · lead sponsor · 2023-08-07
ENROLLING_BY_INVITATION
A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-ArmNCT05555342 · lead sponsor · 2023-01-03
COMPLETED
Skills-Based Educational Strategies for Reduction of Vascular Events in Orange CountyNCT05641519 · lead sponsor · 2022-11-18
ACTIVE_NOT_RECRUITING
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint InhibitorsNCT05334329 · lead sponsor · 2022-07-20
ACTIVE_NOT_RECRUITING
Dietary Sodium Intake and Blood Pressure in Living Kidney DonorsNCT05041829 · lead sponsor · 2021-11-03
SUSPENDED
Mi Propio Camino Intervention RCT for Blood Pressure Medication AdherenceNCT04585594 · lead sponsor · 2020-09-16
COMPLETED
Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast CancerNCT04305236 · lead sponsor · 2020-07-23
TERMINATED
Dexcom G6 Continuous Glucose Monitoring in HemodialysisNCT04217161 · lead sponsor · 2020-03-01
UNKNOWN
Study Of Drinks With Artificial Sweeteners in People With Type 2 DiabetesNCT03944616 · lead sponsor · 2019-06-06
COMPLETED
Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZNCT03935685 · lead sponsor · 2019-02-26
ACTIVE_NOT_RECRUITING
Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIVNCT03702049 · lead sponsor · 2019-01-24
COMPLETED
Dietary Approaches for Cardiometabolic HealthNCT03527290 · lead sponsor · 2018-01-15
COMPLETED
Ethnic Influences on Stress, Energy Balance and Obesity in AdolescentsNCT03369691 · lead sponsor · 2017-12-16
COMPLETED
Nicotinamide as an Early Alzheimer's Disease TreatmentNCT03061474 · lead sponsor · 2017-07-12
COMPLETED
Emotional Response in Psychiatric and Control ParticipantsNCT03056781 · lead sponsor · 2017-02-15
COMPLETED
Early Prostate Cancer: Predicting Treatment ResponseNCT03770351 · lead sponsor · 2017-01-01
UNKNOWN
HOPE Social Media Intervention for HIV Testing and Studying Social NetworksNCT02944877 · lead sponsor · 2016-12-01
COMPLETED
Unidas Por la Vida: A Healthy Lifestyle Intervention for High-risk Latina DyadsNCT02741037 · lead sponsor · 2016-01-01
COMPLETED
Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) SystemNCT02690805 · lead sponsor · 2015-05-01
COMPLETED
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or BevacizumabNCT02436993 · lead sponsor · 2015-04-01
ACTIVE_NOT_RECRUITING
Breast Tumor Oxygenation During ExerciseNCT02340468 · lead sponsor · 2015-04-01
WITHDRAWN
The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication AdherenceNCT02324036 · lead sponsor · 2014-12-01
COMPLETED
A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic WomenNCT02527018 · lead sponsor · 2014-11-01
COMPLETED
The Effect of 10-Week Exercise Training on Children With AsthmaNCT03716219 · lead sponsor · 2013-10-10
WITHDRAWN
MRI Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal BalloonNCT01979848 · lead sponsor · 2013-06-01
COMPLETED
Transurethral Ultrasonic Imaging For Detection and Classification of Prostate CancerNCT02307552 · lead sponsor · 2013-06-01
TERMINATED
A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesNCT01939483 · lead sponsor · 2012-12-01
WITHDRAWN
Test of an Intervention to Increase Physical Activity Among School ChildrenNCT01876602 · lead sponsor · 2011-04-01
COMPLETED
Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic ImagingNCT01277263 · lead sponsor · 2010-12-01
WITHDRAWN
Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic ImagingNCT01257932 · lead sponsor · 2010-12-01
WITHDRAWN
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer PatientsNCT01882985 · lead sponsor · 2010-12-01
COMPLETED
Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)NCT01215721 · lead sponsor · 2010-10-01
COMPLETED
Effects of a High Protein Diet on Clinical Outcomes in Heart FailureNCT01423266 · lead sponsor · 2009-12-01
COMPLETED
Use of Hypothermia During Robotic ProstatectomyNCT00915031 · lead sponsor · 2009-08-01
COMPLETED
Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) ScanningNCT00937261 · lead sponsor · 2009-07-01
UNKNOWN
A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With LurasidoneNCT01979679 · lead sponsor · 2008-12-01
COMPLETED

Drugs studied in this sponsor's trials

30 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of California, Irvine as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
bevacizumab3
carboplatin3
trastuzumab3
abemaciclib2
cyclophosphamide2
fulvestrant2
niacinamide2
placebo2
bevacizumab RxCUI 253337 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials carboplatin RxCUI 40048 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials trastuzumab RxCUI 224905 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials abemaciclib RxCUI 1946825 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials cyclophosphamide RxCUI 3002 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials fulvestrant RxCUI 282357 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials niacinamide RxCUI 7405 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials placebo RxCUI 8375 · Lead sponsor in 2 linked trial(s) · 2 currently recruiting 2 trials riluzole RxCUI 35623 · Lead sponsor in 2 linked trial(s) · 2 currently recruiting 2 trials abacavir RxCUI 190521 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial anastrozole RxCUI 84857 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial aspirin 81 MG Delayed Release Oral Tablet RxCUI 308416 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial cefazolin RxCUI 2180 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial dasatinib RxCUI 475342 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial docetaxel RxCUI 72962 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial doxorubicin RxCUI 3639 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial filgrastim RxCUI 68442 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial fludarabine RxCUI 24698 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial irinotecan hydrochloride RxCUI 153329 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial paclitaxel RxCUI 56946 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial paclitaxel protein-bound RxCUI 486610 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial paliperidone RxCUI 679314 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial pegfilgrastim RxCUI 338036 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial pertuzumab RxCUI 1298944 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor87
collaborator37
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.